⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
High antipsychotic prescribing (65+)High fills per patient
Risk indicators are statistical patterns, not allegations. Learn more
10,421
Total Claims
$1.4M
Drug Cost
437
Beneficiaries
$3,223
Cost/Patient
Risk Score Breakdown 15/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
High fills per patient+3
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+174%
Cost per patient vs peers
$3,223 vs $1,174 avg
+91%
Brand preference vs peers
17.0% vs 8.9% avg
Brand vs Generic
83% generic
Brand: 1,738 claims · $1.2M
Generic: 8,510 claims · $151K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 121 | $145K |
| Semaglutide | 101 | $121K |
| Fluticasone/Umeclidin/Vilanter | 125 | $102K |
| Empagliflozin | 119 | $91K |
| Tirzepatide | 65 | $73K |
| Mepolizumab | 13 | $47K |
| Insulin Glargine,hum.Rec.Anlog | 57 | $47K |
| Aripiprazole | 15 | $43K |
| Rivaroxaban | 47 | $41K |
| Rifaximin | 13 | $40K |
| Mirabegron | 46 | $36K |
| Dapagliflozin Propanediol | 52 | $36K |
| Linaclotide | 38 | $33K |
| Apixaban | 47 | $27K |
| Insulin Degludec | 35 | $25K |
Prescribing Profile
Patient Profile
70
Avg Age
60%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About